SCLP — Scancell Holdings Share News
0.000.00%
- £112.74m
- £121.25m
Scancell Holdings - Director Dealing
Scancell Holdings - Director/PDMR Shareholding
Brief: Scancell Holdings Reports Strong Phase 2 Data On iSCIB1+ In Melanoma
Scancell Holdings - Strong Phase 2 data on iSCIB1+ in Melanoma
Scancell Holdings - Share Option Exercise
Brief: Scancell Initiates New Arm In SCOPE Phase 2 Study
Scancell Hlds - Scancell initiates new arm in SCOPE Phase 2 study
Scancell Hlds - Director Dealing
Brief: Scancell Holdings Announces Partnership With NHS Cancer Vaccine Launch Pad
Press Digest: Financial Times - April 14
Scancell Hlds - Scancell to present at 2025 AACR Annual Meeting
Scancell Hlds - Issue of share options
Scancell Hlds - Interim Results
Scancell Hlds - Notice of Interim Results
Brief: Scancell Holdings Says Raised Total Gross Proceeds Of £10.3 Mln
Scancell Hlds - Result of Placing and Subscription
Brief: Scancell Holdings Announces Retail Offer For Up To £1 Mln
Brief: Scancell Holdings Proposed Fundraise In Excess Of £8.5 Mln
Scancell Hlds - Retail Offer for up to £1 million